It’s time to nominate your favorite private biotech for this year’s Endpoints 11

I’ve got a query for you today.

Do you know a truly great private biotech out there with outstanding management, super science, ambitious and novel drug development plans, and the resources and backing needed to see the game out to pivotal data?

If you’ve been reading Endpoints News for awhile, you’ll know why I’m asking. Every year for a stretch that now exceeds many of your careers, I’ve been assembling a roster of private — let me emphasize the private part — biotechs that deserve to be specially recognized for their efforts.

The Endpoints 11 has long been my favorite project of the year. We plan to head to the State Room in Boston on the evening of Sept. 26 to publicly celebrate this year’s selection of remarkable and noteworthy companies. Like last year, I’ll be relying on lots of help for this as we navigate the selection process, with…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks